Evolution of mRNA-based vaccines: a regulator’s view

Charlotte Barker, Commissioning Editor, Vaccine Insights, speaks with Ka-Wai Wan, Senior Pharmaceutical Assessor, Medicines and Healthcare products Regulatory Agency, about pandemic preparedness, the regulatory pathway for mRNA-based vaccines, and the opportunities and challenges posed by their rapid evolution.

Please enter your email to access content Read now